Researchers at the Indian Institute of Technology Roorkee (IIT Roorkee) have identified specific bioactive compounds within cow urine distillate (CUD) that exhibit significant antiviral activity against the Chikungunya virus (CHIKV). This study, published on June 19, 2026, in the journal ACS Agricultural Science & Technology, provides a quantitative basis for evaluating traditional Ayurvedic preparations through modern biochemical analysis.
The investigation was led by Prof. Shailly Tomar from the Department of Biosciences and Bioengineering at IIT Roorkee. Her team utilized a multi-disciplinary approach, integrating metabolomics, molecular docking, and advanced virology to isolate the active constituents responsible for suppressing viral replication.
Laboratory results indicated that treatment with CUD reduced Chikungunya viral levels by more than 90 percent at concentrations deemed safe for cellular health. The research team further optimized this efficacy by creating a synergistic formulation that included thymoquinone, derived from Nigella sativa, and piperine, extracted from black pepper.
This specific combination of CUD, thymoquinone, and piperine achieved a viral load reduction of 99.85 percent under controlled laboratory conditions. The researchers identified benzoic acid, hippuric acid, and oleic acid as the primary constituents driving this antiviral effect.
These identified molecules function by interfering with critical viral proteins required for the replication cycle of the Chikungunya virus. By targeting these protein pathways, the compounds effectively disrupt the virus’s ability to propagate within host cells.
The project received support from the Ministry of AYUSH, reflecting a broader institutional effort to bridge traditional knowledge systems with contemporary biotechnology. This collaboration aims to develop affordable, scientifically validated therapeutic options for viral diseases that currently lack robust treatment protocols.
The study involved extensive laboratory validation and computational screening to ensure the accuracy of the findings. By applying rigorous scientific standards to traditional substances, the team sought to isolate the specific chemical mechanisms that contribute to the observed antiviral properties.
Prof. Kamal Kishore Pant, Director of IIT Roorkee, emphasized the necessity of such interdisciplinary efforts in addressing global health crises. He noted that the integration of traditional medicine with modern scientific rigor is essential for creating innovative and accessible medical solutions.
Prof. Shailly Tomar highlighted the implications of these findings for future drug development strategies. She stated that the research establishes a foundation for exploring natural bioactive molecules as potential candidates for novel antiviral interventions against Chikungunya and related pathogens.
Our research not only identifies specific bioactive molecules in Ayurvedic Gau mutra ark responsible for antiviral activity but also demonstrates the power of synergistic natural formulations. These findings provide a strong foundation for developing advanced antiviral strategies against Chikungunya and potentially other related viral infections. Further pre-clinical and translational studies will be essential to evaluate their therapeutic applicability.
The Chikungunya virus, primarily transmitted by Aedes mosquitoes, remains a significant public health burden due to the severe fever and debilitating joint pain it causes in infected individuals. Current medical options for treating the infection are limited, making the identification of new, effective compounds a priority for researchers.
The research team intends to conduct further investigations to determine the precise molecular mechanisms of these compounds in diverse cellular environments. By clarifying how these biological agents interact with host cell membranes, the researchers hope to optimize the bioavailability and therapeutic window of the distillate.
Future research will focus on pre-clinical and translational studies to determine the therapeutic viability and safety profile of these compounds in human models. These subsequent investigations are necessary to transition the findings from laboratory-scale validation to potential clinical applications in managing mosquito-borne viral diseases.
